Salvage HDR brachytherapy for prostate cancer: a high-volume center experience on 100 consecutive patients.

Lauri MäkeläRobin BergrothLauri TaipaleSara TornbergHarri Visapää

Published in: Scandinavian journal of urology (2023)

This retrospective study shows that salvage HDR brachytherapy is a well-tolerated and effective treatment for histologically proven, local radio-recurrent disease.

Keyphrases

prostate cancer
high dose
radiation therapy
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
radical prostatectomy
locally advanced
low dose
squamous cell carcinoma
combination therapy